Dr. Stan Kutcher, a co-author of a widely disseminated–now discredited ghostwritten report–“Study 329”–who ran for Canadian Parliament, The Coast, a small Canadian newspaper, retracted and then apologized for a story that highlighted about the benefits of the antidepressant, Paxil, for children.
professor of psychiatry who penned his name to aghostwritten report
Given multiple prior investigations of Dr. Wakefied’s 1998 paper, why did it take the Lancet editors 12 years to discover a lack of proper IRB approval?
AHRP has sent a letter of complaint to the American Medical Association and the JAMA Oversight Committee calling for a public apology to Dr. Jonathan Leo by the AMA, a thorough investigation, the immediate suspension of the two editors involved, and a commitment to reviewing, clarifying and publishing JAMA’s editorial policies to protect against future violations of standards for professional conduct
JAMA Editor Ignites Firestorm By Calling Critic a ‘Nobody and a Nothing’_WSJ
The video, "Zyprexa Drug Rep," was posted on YouTube on Dec. 18. When AHRP publicized its (Jan 4) there were something on the order of 38 hits. Since the Infomail was posted on the AHRP website and blog (http://ahrp.blogspot.com the number has reached: 1,429.
"Biological psychiatrists have looked very closely for a serotonin imbalance or dysfunction in patients with depression or obsessive compulsive disorder and, to date, it has been elusive," says Dr. Wayne Goodman, Chair of the US Food and Drug Administration (FDA) Psychopharmacologic Drugs Advisory Committee.
The importance of debate in science cannot be overstated. Without the challenge of debate, science is dominated by "authorities" who provide only the veneer of science without substance supported by evidence. Correct url for power point: https://ahrp.org/children/teenscreen/debateNAS0206.ppt
"Serotonin and depression: A disconnect between the advertisements and the scientific literature."
"Some 19 million people in the U.S. suffer from depression in any given year. For many, SSRIs help little, if at all. To do better, we have to get the science right." Sharon Begley, Wall Street Journal
